Literature DB >> 5214488

Where do we stand with reserpine and anesthesia?

M H Alper.   

Abstract

Mesh:

Substances:

Year:  1965        PMID: 5214488      PMCID: PMC2077814     

Source DB:  PubMed          Journal:  J Am Dent Soc Anesthesiol


× No keyword cloud information.
  11 in total

1.  THE INFLUENCE OF RESERPINE PRETREATMENT UPON THE HEMODYNAMICS OF DOGS DURING HEMORRHAGIC HYPOTENSION.

Authors:  E SEIFEN; W FLACKE; M H ALPER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-04-21

Review 2.  PHARMACOLOGY OF RESERPINE AND ITS IMPLICATIONS FOR ANESTHESIA.

Authors:  M H ALPER; W FLACKE; O KRAYER
Journal:  Anesthesiology       Date:  1963 Jul-Aug       Impact factor: 7.892

3.  Release of serotonin and catecholamines by drugs.

Authors:  P A SHORE
Journal:  Pharmacol Rev       Date:  1962-12       Impact factor: 25.468

4.  Effect of anesthetic agents on patients receiving reserpine therapy.

Authors:  W M MUNSON; J A JENICEK
Journal:  Anesthesiology       Date:  1962 Nov-Dec       Impact factor: 7.892

5.  Effect of denervation and of reserpine treatment on transmission at sympathetic nerve endings.

Authors:  G BURNSTOCK; M E HOLMAN
Journal:  J Physiol       Date:  1962-03       Impact factor: 5.182

6.  Persisting effects of reserpine in man.

Authors:  D X FREEDMAN; A J BENTON
Journal:  N Engl J Med       Date:  1961-03-16       Impact factor: 91.245

7.  Circulatory actions of general anesthetic agents and the homeostatic roles of epinephrine and norepinephrine in man.

Authors:  H L PRICE
Journal:  Clin Pharmacol Ther       Date:  1961 Mar-Apr       Impact factor: 6.875

8.  The release of norepinephrine from the mammalian heart by reserpine.

Authors:  M K PAASONEN; O KRAYER
Journal:  J Pharmacol Exp Ther       Date:  1958-06       Impact factor: 4.030

9.  The pharmacology of Rauwolfia.

Authors:  H J BEIN
Journal:  Pharmacol Rev       Date:  1956-09       Impact factor: 25.468

10.  Human pharmacology of reserpine.

Authors:  T WINSOR
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

View more
  2 in total

Review 1.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

2.  Individualizing premedication.

Authors:  R M Smith
Journal:  Anesth Prog       Date:  1966-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.